drugset / Trial / NCT00847535
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
RandomizedSingle-groupOpen-labelTreatment
Summary
This is a clinical investigation approved by US FDA and Canadian Health Authority to study the safety and potential effectiveness of the autologous muscle cells for the treatment of stress urinary incontinence.
Timeline
- Start
- 2008-10-09
- Primary completion
- 2011-11-02
- Completion
- 2011-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous muscle cells | Cell therapy | — | Other |